A 3-Parts, randomized, double-blind, placebo-controlled, single and multiple ascending-dose study evaluating the safety, pharmacokinetics and tolerability of delafloxacin in healthy volunteers

Trial Profile

A 3-Parts, randomized, double-blind, placebo-controlled, single and multiple ascending-dose study evaluating the safety, pharmacokinetics and tolerability of delafloxacin in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs Delafloxacin (Primary)
  • Indications Skin and soft tissue infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 27 Nov 2015 New trial record
    • 12 Nov 2015 Results published in the Clinical Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top